- The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance2010 | First Faculty of Medicine
- Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)2019 | First Faculty of Medicine
- Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients2019 | First Faculty of Medicine
- Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers2011 | First Faculty of Medicine
- Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa2009 | First Faculty of Medicine
- Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge2017 | First Faculty of Medicine
- Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome2010 | First Faculty of Medicine
- Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers2011 | Second Faculty of Medicine
- The Effect of Colesevelam Treatment on Bile Acid and Lipid Metabolism and Glycemic Control in Healthy Men2016 | First Faculty of Medicine
- Chyme Reinfusion Restores the Regulatory Bile Salt-FGF19 Axis in Patients With Intestinal Failure2021 | First Faculty of Medicine
- Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus2016 | First Faculty of Medicine, Faculty of Physical Education and Sport